Browse Category

TSX:VHI News 16 January 2026

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 16.01.2026

Hanover Insurance Group closed at $169.96, about 15% below its estimated fair value of $200.13, with analysts projecting 4.3% annual revenue growth. Vitalhub shares ended at CA$8.45, down 17.5% over 90 days, despite a fair value estimate of CA$15.53. Sampo Oyj traded at €10.00, showing a 24.9% discount to its €13.32 intrinsic value based on the Excess Returns model.

16 January 2026

HEX:SAMPO·NYSE:THG·Stock Market·TSX:VHI

Intuitive Machines stock just jumped 18% — what LUNR traders are watching next week

7 February 2026

Intuitive Machines shares surged 18.3% to $17.50 Friday, outpacing the broader market as the Dow topped 50,000 and tech stocks rallied. No clear company-specific news drove the jump. The move follows last month’s $800 million Lanteris Space Systems acquisition. U.S. jobs and inflation data next week may shift market direction.

GE Vernova stock price jumps toward $800 — what to know before Monday trade

7 February 2026

GE Vernova shares jumped 5.7% to $779.35 Friday after Baird upgraded the stock and the Dow closed above 50,000. The company’s onshore wind unit reported 1.1 GW in U.S. repower orders for 2025, a figure previously disclosed. GE Vernova also completed a $2.6 billion senior notes offering to help fund its Prolec GE stake purchase. Next earnings report is set for April 22.

Navitas Semiconductor stock jumps 19% into weekend — here’s what could move NVTS next week

7 February 2026

Navitas Semiconductor shares surged 19.3% to $8.86 Friday, with 27.4 million shares traded, as chip stocks rebounded and the Dow closed above 50,000 for the first time. The company’s next earnings report is scheduled for February 24 after market close.

Lumentum stock hits a record close — Citi raises target, insider filing lands ahead of Monday

7 February 2026

Lumentum shares jumped 9.3% to a record $551.99 Friday after Citigroup and JPMorgan raised price targets to $560 and $565. The surge followed strong quarterly results and guidance, plus a director’s filing to sell up to 4,849 shares. Markets reopen Monday ahead of the company’s March 17 investor briefing at OFC.

Go toTop